Evidence map›Paper›PMID 28849163›Full record

ArticleInternational journal of oncology2017

Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway.

Sandeep Shrestha, Jiabin Zhu, Qi Wang, Xiaohui Du, Fen Liu, Jianing Jiang, Jing Song, Jinshan Xing, Dongdong Sun, Qingjuan Hou and 4 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Curcumin and Endometriosis.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sandeep ShresthaDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 16011, P.R. China.
Jiabin ZhuDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 16011, P.R. China.
Qi WangDepartment of Respiratory Medicine, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Xiaohui DuScientifc Research Center, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Fen LiuDepartment of Respiratory Medicine, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Jianing JiangDepartment of Respiratory Medicine, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Jing SongDepartment of Respiratory Medicine, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Jinshan XingDepartment of Neurosurgery, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Dongdong SunCollege of Pharmacy, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Qingjuan HouCollege of Pharmacy, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Yulin PengCollege of Pharmacy, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Jun ZhaoDepartment of Neurosurgery, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China.
Xiuzhen SunDepartment of Otorhinolaryngology, Affiliated Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.
Xishuang SongDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 16011, P.R. China.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin, a natural polyphenolic compound, has commonly been used as a food additive or in many traditional medicine remedies for over 2,000 years in many Asian countries. Melatonin is a hormone secreted from pineal glands of mammals and possesses diverse physiological functions. Both curcumin and melatonin have the effective potential to inhibit proliferation of various types of cancers, but there is no report on their combination for bladder cancer treatment, and the underlying mechanism remains poorly understood. In the present study, we investigated whether the combination of curcumin and melatonin leads to an enhanced inhibition of cell proliferation in bladder cancer cells. Our results showed that the combinational treatment enhanced the repression of nuclear translocation of NF-κB and their binding on COX-2 promoter via inhibiting IKKβ activity, resulting in inhibition of COX-2 expression. In addition, combined treatment with curcumin and melatonin induced cell apoptosis in bladder cancer through enhancing the release of cytochrome c from the mitochondrial intermembrane space into the cytosol. These results, therefore, indicated that melatonin synergized the inhibitory effect of curcumin against the growth of bladder cancer by enhancing the anti-proliferation, anti-migration, and pro-apoptotic activities, and provide strong evidence that combined treatment with curcumin and melatonin might exhibit an effective therapeutic option in bladder cancer therapy.

Indexed as

AnimalsAntineoplastic Combined Chemotherapy ProtocolsCell Cycle CheckpointsCell Line, TumorCell ProliferationCurcuminCyclooxygenase 2Cyclooxygenase 2 InhibitorsDrug SynergismHeterograftsHumansI-kappa B KinaseMaleMelatoninMiceMice, Inbred BALB CCurcuminCyclooxygenase 2Cyclooxygenase 2 InhibitorsI-kappa B KinaseIKBKB protein, humanMelatoninNF-kappa BPTGS2 protein, human

Identifiers

PMID28849163
PMCPMC5592853
OpenAlexW2748629056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.